pulmonaryfibrosisnews10d
Trial: LYT-100 better than Esbriet in slowing lung function decline in IPF
Therapy candidate LYT-100 worked better than Esbriet, with fewer side effects, to slow lung function decline in IPF patients, ...
pulmonaryfibrosisnews13d
Ways to handle the isolation that can come with the holidays
Columnist Sam Kirton, who has IPF, has often needed to isolate during the holidays. Here he shares some ways he's stayed connected anyhow.
pulmonaryfibrosisnews13d
Podcasts & Flash Briefings
Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.
pulmonaryfibrosisnews10d
Pulmonary Fibrosis News
Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.
pulmonaryfibrosisnews16d
Enrollment hits 75% for Phase 2b clinical trial of Haduvio for IPF
A Phase 2b clinical trial testing Haduvio for IPF cough reached 75% of targeted enrollment but is still recruiting patients ...
pulmonaryfibrosisnews24d
First patient dosed in Phase 2b clinical trial of ENV-101 for IPF
The first patient has been dosed in a Phase 2b clinical trial of Endeavor Biomedicines’ investigational oral therapy ENV-101 (taladegib) in people with idiopathic pulmonary fibrosis (IPF). WHISTLE-PF ...
pulmonaryfibrosisnews27d
This holiday season, I’m honoring the gift of time
Welcome to December. Wait, what? How is it December? Time seemed to move in slow motion during the height of the COVID-19 pandemic, and now it’s already the end of 2024. In 1974, the Rolling Stones ...